The initiatives we're taking speak again to what some of my colleagues here have mentioned in terms of opportunities for partnerships, wherein we want businesses to partner with our scientists, if you will. We want our scientists to understand business a bit better, so there's a cooperation and harmony between the two fronts.
On publishing, scientists—and frankly, professors at university—will tell you they are rewarded for publishing. In my view, publishing, while it's a great place to be, is like second base. It's not the home run. When the knowledge that is developed by the scientist, especially if it's funded by federal dollars in any way, is transferred out of the laboratory into something—a process, an application, a product, a different way of treating patients, etc.—that knowledge transfer completes the cycle.
In doing that, you have the medical isotopes that are necessary for the next-generation diseases, you have customized health care that can diagnose situations much faster, more accurately, and then, of course, treatment protocols that are more effective and less expensive.